Loading...
By the Editors
This week, the World Health Organization recommended use of systemic corticosteroids for severe COVID-19 after a meta-analysis and randomized controlled trials showed positive results. Elsewhere, a study examined the rise in depression during the pandemic. Over in Iceland, researchers found that antibody response to SARS-CoV-2 infection may be durable through 4 months' follow-up.
Comment
LINK(S):
COVID-19 Fatality Rate for Seniors More Than Twice as High as Flu (Sept. 3) ()
WHO Recommends Corticosteroids for Severe COVID-19 After Positive Study Results (Sept. 2) (Free)
COVID-19: Depression / Time to Viral Clearance / Nanoparticle Vaccine / NIH & Convalescent Plasma (Sept. 2) (Free)
COVID-19: Airborne Transmission / Antibody Response / Outcomes in Pregnancy (Sept. 1) (Free)
Asthma Might Not Be a Risk Factor for Severe COVID-19 (Aug. 31) (Free)
COVID-19: Saliva Testing / Virus Detection in Children / Remdesivir Authorization Expanded / Reinfection in U.S. (Aug. 30) (Free)